Bonjour à tous,
Vous trouverez ci-dessous les titres des publications des membres du réseau ENDOCAN TUTHYREF.
Félicitations aux auteurs!
Retrouvez les publications dans :
Mai/Juin 2026
- Chaib S, Castellnou S, Keniza T, Daru E, Triplet A, Abeillon J, Tylski P. Estimation of the delay for resumption of breastfeeding after 131-iodine therapy by milk radioactivity measurement. Eur Thyroid J. 2026 Jun 24:ETJ-26-0012. doi: 10.1530/ETJ-26-0012. Epub ahead of print. PMID: 42340811. Voir fichier : Chaib2026-Estimation-of-the-delay.pdf
- Chevalier B, Devos L, Baillet C, Jannin A, Fages V, Dekyndt B, Legrand JF, Do Cao C, Huglo D, Provôt F, Beron A, Lion G, Maurice JB. Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience. J Nucl Med. 2026 May 14:jnumed.125.271707. doi: 10.2967/jnumed.125.271707. Epub ahead of print. PMID: 42134980. Voir fichier : Chevalier2026-Management-of-Hemodialyzed;pdf
- Fusella Giuntini M, Voyant C, Taieb D, Barbolosi D. A computational framework for optimizing radioiodine therapy protocols in metastatic thyroid cancer. Sci Rep. 2026 Jun 14. doi: 10.1038/s41598-026-56267-1. Epub ahead of print. PMID: 42289454. Voir fichier : Fusella-Giuntini2026-A-computational-framework.pdf
- Hartl DM, Schlumberger M. Rethinking prophylactic central neck dissection in clinically node-negative papillary thyroid cancer. Lancet Diabetes Endocrinol. 2026 Jul;14(7):608-616. doi: 10.1016/S2213-8587(26)00071-9. Epub 2026 May 11. PMID: 42114521. Voir fichier : Hartl2026- Rethinking-prophylactic.pdf
- Kuhlen M, Roganivic J, Naviglio S, Baecklund F, Bello R, Ben-Ami T, Bergamaschi L, Bilic E, Bien E, Brito MJ, Castañeda A, Cesen Mazic M, Dos Reis Farinha NJ, Jovanovska A, de Krijger R, Debora de Pasquale M, Elisei R, Grau Bolado G, Guillén G, Haissaguerre M, Hartl D, Huerta-Aragonés J, Krawczyk MA, Lamartina L, Leite F, Leite V, López Almaraz R, Manevska N, Mansuy L, Miele E, Naderi EH, Nordmann Winther T, Petit IO, Özön ZA, Podda MG, Pourtsidis A, Reguerre Y, Sandström M, Schneider DT, Ekinci S, Suput Omladic J, Sztangierska B, Verite C, Waespe N, Wong KH, Yalcin B, Abele M, Bisogno G, Orbach D, Brecht IB, Virgone C, Redlich A. Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice-an European Cooperative Study Group for Paediatric Rare Tumours survey. Eur J Endocrinol. 2026 Jun 1;194(6):756-768. doi: 10.1093/ejendo/lvag091. PMID: 42139545. Voir fichier : Kuhlen2026-European-paediatric.pdf
- Ory C, Jouannet C, Panunzi L, Nouira A, Benderitter M, Le Guen B, Schlumberger M, de Vathaire F, Deleuze JF, Bogdanova TI, Tronko M, Pushkarev VV, Masiuk S, Souidi M, Benadjaoud MA. Post-Chornobyl thyroid papillary carcinomas display distinct past 131I exposure and radiation-associated carcinogenesis molecular signatures at low and high thyroid doses. Sci Rep. 2026 May 18. doi: 10.1038/s41598-026-53030-4. Epub ahead of print. PMID: 42151323. Voir fichier : ory2026-Post-Chornobyl.pdf
- Terroir M, Lusque A, Hindié E, Taieb D, Eberle-Pouzeratte MC, Verbeke S, Decote A, Grunenwald S, Zerdoud S. Prospective study on the [18F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery. Eur J Nucl Med Mol Imaging. 2026 Jun 24. doi: 10.1007/s00259-026-07992-2. Epub ahead of print. PMID: 42337037. Voir fichier : terroir 2026-prospective.pdf
